Clinical Trials Update: Dec. 23, 2010
Alzheimer's Disease (Ages 50-89) Ovarian Cancer Influenza
(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
Alzheimer's Disease (Ages 50-89)
This is a phase III clinical trial to evaluate an investigational treatment for mild-to-moderate Alzheimer's disease.
The research site is in Las Vegas, Nev.
This clinical research study is investigating whether an investigational drug is safe and effective when given in combination with carboplatin and taxane for women who have platinum-sensitive epithelial ovarian cancer that relapsed between 6 and 24 months after first-line treatment with a platinum-containing chemotherapy regimen.
The research site is in Hackensack, N.J.
This study is for people who believe they have the flu. To qualify, you must have flu-like symptoms that began in the past 48 hours.
The research site is in Council Bluffs, Ia.
Copyright 2010 ClinicalConnection.com. All rights reserved.